or Try an Advanced Search...

    Technical Analysis for WGS - GeneDx Holdings Corp.

    Grade Last Price % Change Price Change
    C 69.38 -2.34% -1.66
    WGS closed down 2.34 percent on Wednesday, November 20, 2024, on 73 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Down
    Historical WGS trend table...
    Date Alert Name Type % Chg
    Boomer Buy Setup Bullish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Multiple of Ten Bearish Other 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    20 DMA Resistance Bearish -2.34%
    1,2,3 Pullback Bullish Bullish Swing Setup -2.34%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.34%
    NR7 Range Contraction -2.34%
    Older End-of-Day Signals for WGS ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 16 hours ago
    Down 2 % about 16 hours ago
    Down 1% about 16 hours ago
    Possible NR7 about 16 hours ago
    Possible Inside Day about 16 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    WGS Chart by TradingView
    Basic chart:

    Profile

    GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its industry-leading exome and genome testing and interpretation, fueled by one of the world’s largest rare disease data sets.
    Classification
    Sector: Healthcare
    Industry: Health Information Services
    Keywords: Biology Emerging Technologies Drug Discovery Molecular Biology Genomics Precision Medicine Systems Biology Evidence Based Medicine Personal Genomics

    Is WGS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 19 GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
    Nov 18 GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary
    Nov 16 Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Year
    Nov 16 Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
    Nov 8 Southwest Airlines, Samsara, Nathan’s, and More Stocks See Action From Activist Investors
    Nov 7 New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
    Nov 5 Zacks.com featured highlights include Snap, GeneDx and Leonardo
    Nov 4 GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
    Nov 4 3 Stocks to Buy for Stellar Earnings Acceleration in November
    Nov 4 Best Momentum Stocks to Buy for November 4th
    See more WGS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 89.1099
    52 Week Low 1.41
    Average Volume 626,610
    200-Day Moving Average 30.14
    50-Day Moving Average 58.11
    20-Day Moving Average 73.10
    10-Day Moving Average 73.55
    Average True Range 6.15
    RSI (14) 51.69
    ADX 34.46
    +DI 19.55
    -DI 15.82
    Chandelier Exit (Long, 3 ATRs) 70.65
    Chandelier Exit (Short, 3 ATRs) 73.76
    Upper Bollinger Bands 88.18
    Lower Bollinger Band 58.02
    Percent B (%b) 0.38
    BandWidth 41.26
    MACD Line 3.67
    MACD Signal Line 5.45
    MACD Histogram -1.7772
    Fundamentals Value
    Market Cap 1.8 Billion
    Num Shares 25.9 Million
    EPS -35.44
    Price-to-Earnings (P/E) Ratio -1.96
    Price-to-Sales 0.51
    Price-to-Book 0.39
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 74.51
    Resistance 3 (R3) 74.63 73.05 73.66
    Resistance 2 (R2) 73.05 71.74 72.99 73.37
    Resistance 1 (R1) 71.21 70.93 70.42 71.09 73.08
    Pivot Point 69.63 69.63 69.23 69.57 69.63
    Support 1 (S1) 67.79 68.32 67.00 67.67 65.68
    Support 2 (S2) 66.21 67.51 66.15 65.39
    Support 3 (S3) 64.37 66.21 65.11
    Support 4 (S4) 64.25